Dr Reddy's Laboratories Ltd (NYSE:RDY)
| 54.74 Delayed Data As of Mar 24 |  +0.26 / +0.48%Today’s Change | 49.59 Today|||52-Week Range 58.28 | +5.78% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Revenue and Income | Net Revenues | 2.4B | 2.1B | 2.2B | 2.2B | |
| Cost of Goods Sold | 871.5M | 835.5M | 917.1M | 910.1M | ||
| Depreciation And Amortization | 156.2M | 168.3M | 181.6M | 174.3M | ||
| Operating Expenses | Gross Income | 1.3B | 1.1B | 1.1B | 1.1B | |
| General Expenses | 891.0M | 904.9M | 930.7M | 843.0M | ||
| Other Operating Expenses | 0.00 | 0.00 | 0.00 | -7.6M | ||
| Research And Development | 255.4M | 272.9M | 264.2M | 205.5M | ||
| Total Operating Expenses | 1.9B | 1.9B | 2.0B | 1.9B | ||
| Non-Operating Expenses | Operating Income | 439.0M | 192.1M | 173.4M | 280.0M | |
| Extraordinary Credit | 0.00 | 6.2M | 0.00 | 4.4M | ||
| Extraordinary Charge | -929.6K | -6.6M | -822.0K | -1.7M | ||
| Interest Expense On Debt | 76.4M | 14.3M | 20.4M | 23.1M | ||
| Equity In Earnings | 3.5M | 5.2M | 5.3M | 6.3M | ||
| Other Expenses | 26.3M | 22.8M | 48.3M | 33.6M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 410.1M | 213.4M | 217.1M | 314.6M | |
| Income Taxes | -108.6M | -39.0M | -70.3M | -52.2M | ||
| Net Income | 305.0M | 179.6M | 152.1M | 268.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 170.5M | 166.6M | 165.8M | 165.9M | |
| Shares To Calculate EPS Diluted | 171.1M | 167.0M | 166.2M | 166.2M | ||
| Earnings Per Share | EPS | $1.79 | $1.08 | $0.92 | $1.62 | |
| EPS Diluted | $1.78 | $1.08 | $0.92 | $1.62 | ||
